News | October 07, 2010

Court Rules in Favor of Volcano in OCT Case

October 7, 2010 – The Superior Court of Massachusetts has ruled against LightLab Imaging in the company’s optical coherence tomography (OCT) trade secret case against Volcano and its wholly owned subsidiary, Axsun Technologies. LightLab Imaging is a wholly owned subsidiary of St. Jude Medical.

LightLab was purchased in May by St. Jude after the company gained U.S. Food and Drug Administration (FDA) clearance for its OCT intravascular imaging system. It is the first OCT system cleared for use in the United States. Both LightLab and Volcano have OCT systems cleared for commercial use in Europe and Volcano plans to seek FDA clearance for its system.

In a 16-page decision, the court rejected LightLab's claims for protection of five alleged trade secrets relating to laser technologies. It also denied all of LightLab's requests for permanent injunctions. The ruling followed a two-week trial on five of a number of trade secret claims alleged by LightLab. A trial on the remaining trade secret claims has not yet been scheduled.

For more information: www.volcanocorp.com

Related Content

Illustration showing how the near-infrared spectroscopy (NIRS) intravascular ultrasound (IVUS), of NIRS-IVUS, intracoronary imaging system can help identify angiographically non-obstructive lesions with high-risk characteristics for future adverse cardiac outcomes. The system can identify unstable, vulnerable plaques. #TCTconnect #TCT2020

Illustration showing how the near-infrared spectroscopy (NIRS) intravascular ultrasound (IVUS), of NIRS-IVUS, intracoronary imaging system can help identify angiographically non-obstructive lesions with high-risk characteristics for future adverse cardiac outcomes. The system can identify unstable, vulnerable plaques.

News | Intravascular Imaging | October 18, 2020
October 18, 2020 – New data from the...
Philips Launches IntraSight Interventional Applications Platform
Technology | Intravascular Imaging | May 20, 2019
Philips announced the launch of the new IntraSight interventional applications platform. The secure, application-based...
NIRS-IVUS Detects Patients and Plaques Vulnerable to Subsequent Adverse Coronary Events
News | Intravascular Imaging | September 25, 2018
September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-u
Infraredx Announces Japanese Launch of Makoto Intravascular Imaging System and Dualpro IVUS+NIRS Catheter
News | Intravascular Imaging | August 10, 2018
Infraredx Inc. announced the Makoto Intravascular Imaging System, and accompanying Dualpro intravascular ultrasound and...
Technology | Intravascular Imaging | May 02, 2018
May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S.
Avinger, Lightbox L250 imaging console, upgrade, Lumivascular platform, OCT, optical coherence tomography
Technology | Intravascular Imaging | January 11, 2017
January 11, 2017 — Avinger Inc. recently announced the U.S.
IVPA, intravascular photoacoustic imaging, fatty arteries, Purdue, Shanghai

IVPA/IVUS imaging of a perfused fresh human right coronary artery dissected from an explanted heart. (A) IVPA image. (B) IVUS image. (C) Merged IVPA/IVUS image. The 1 mm scale bar applies to all panels.

News | Intravascular Imaging | May 25, 2016
A new imaging system known as intravascular photoacoustic (IVPA) imaging that produces three-dimensional images of the...
PCI, OFDI, OCT, optical coherence tomography, optimal frequency domain imaging, EuroPCR 2016 study
News | Intravascular Imaging | May 20, 2016
Using optimal frequency domain imaging (OFDI) to guide percutaneous coronary intervention (PCI) with second-generation...